Selected research
Industry Research
Radiopharmaceutical Freeze-Dried Products Industry Research Report 2026
Market perspective
The global Radiopharmaceutical Freeze-Dried Products market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Radiopharmaceutical Freeze-Dried Products market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Radiopharmaceutical Freeze-Dried Products market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Radiopharmaceutical Freeze-Dried Products market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Radiopharmaceutical Freeze-Dried Products include Rosatom, NTP, NRG, IRE and ANSTO, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Radiopharmaceutical Freeze-Dried Products market in terms of revenue (US$ million) and, where applicable, service volume (t), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Radiopharmaceutical Freeze-Dried Products.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Radiopharmaceutical Freeze-Dried Products Market by Company
Rosatom
NTP
NRG
IRE
ANSTO
Radiopharmaceutical Freeze-Dried Products Segment by Type
Bone Imaging Kits
Renal (Kidney) Imaging Kits
Cardiac (Heart) Imaging Kits
Others
Radiopharmaceutical Freeze-Dried Products Segment by Application
Hospital
Clinic
Radiopharmaceutical Freeze-Dried Products Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiopharmaceutical Freeze-Dried Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Radiopharmaceutical Freeze-Dried Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiopharmaceutical Freeze-Dried Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Radiopharmaceutical Freeze-Dried Products companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Bone Imaging Kits
- Renal (Kidney) Imaging Kits
- Cardiac (Heart) Imaging Kits
- Others
Applications
- Hospital
- Clinic
Companies covered
- Rosatom
- NTP
- NRG
- IRE
- ANSTO
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Radiopharmaceutical Freeze-Dried Products by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Bone Imaging Kits
- 2.2.3 Renal (Kidney) Imaging Kits
- 2.2.4 Cardiac (Heart) Imaging Kits
- 2.2.5 Others
- 2.3 Radiopharmaceutical Freeze-Dried Products by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Clinic
- 2.4 Assumptions and Limitations
3 Radiopharmaceutical Freeze-Dried Products Breakdown Data by Type
- 3.1 Global Radiopharmaceutical Freeze-Dried Products Historic Market Size by Type (2021-2026)
- 3.2 Global Radiopharmaceutical Freeze-Dried Products Forecasted Market Size by Type (2027-2032)
4 Radiopharmaceutical Freeze-Dried Products Breakdown Data by Application
- 4.1 Global Radiopharmaceutical Freeze-Dried Products Historic Market Size by Application (2021-2026)
- 4.2 Global Radiopharmaceutical Freeze-Dried Products Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Radiopharmaceutical Freeze-Dried Products Market Perspective (2021-2032)
- 5.2 Global Radiopharmaceutical Freeze-Dried Products Growth Trends by Region
- 5.2.1 Global Radiopharmaceutical Freeze-Dried Products Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Radiopharmaceutical Freeze-Dried Products Historic Market Size by Region (2021-2026)
- 5.2.3 Radiopharmaceutical Freeze-Dried Products Forecasted Market Size by Region (2027-2032)
- 5.3 Radiopharmaceutical Freeze-Dried Products Market Dynamics
- 5.3.1 Radiopharmaceutical Freeze-Dried Products Industry Trends
- 5.3.2 Radiopharmaceutical Freeze-Dried Products Market Drivers
- 5.3.3 Radiopharmaceutical Freeze-Dried Products Market Challenges
- 5.3.4 Radiopharmaceutical Freeze-Dried Products Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Radiopharmaceutical Freeze-Dried Products Players by Revenue
- 6.1.1 Global Top Radiopharmaceutical Freeze-Dried Products Players by Revenue (2021-2026)
- 6.1.2 Global Radiopharmaceutical Freeze-Dried Products Revenue Market Share by Players (2021-2026)
- 6.2 Global Radiopharmaceutical Freeze-Dried Products Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Radiopharmaceutical Freeze-Dried Products Head Office and Area Served
- 6.4 Global Radiopharmaceutical Freeze-Dried Products Players, Product Type & Application
- 6.5 Global Radiopharmaceutical Freeze-Dried Products Manufacturers Established Date
- 6.6 Global Radiopharmaceutical Freeze-Dried Products Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Radiopharmaceutical Freeze-Dried Products Market Size (2021-2032)
- 7.2 North America Radiopharmaceutical Freeze-Dried Products Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Radiopharmaceutical Freeze-Dried Products Market Size by Country (2021-2026)
- 7.4 North America Radiopharmaceutical Freeze-Dried Products Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Radiopharmaceutical Freeze-Dried Products Market Size (2021-2032)
- 8.2 Europe Radiopharmaceutical Freeze-Dried Products Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Radiopharmaceutical Freeze-Dried Products Market Size by Country (2021-2026)
- 8.4 Europe Radiopharmaceutical Freeze-Dried Products Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Radiopharmaceutical Freeze-Dried Products Market Size (2021-2032)
- 9.2 Asia-Pacific Radiopharmaceutical Freeze-Dried Products Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Radiopharmaceutical Freeze-Dried Products Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Radiopharmaceutical Freeze-Dried Products Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Radiopharmaceutical Freeze-Dried Products Market Size (2021-2032)
- 10.2 South America Radiopharmaceutical Freeze-Dried Products Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Radiopharmaceutical Freeze-Dried Products Market Size by Country (2021-2026)
- 10.4 South America Radiopharmaceutical Freeze-Dried Products Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Radiopharmaceutical Freeze-Dried Products Market Size (2021-2032)
- 11.2 Middle East & Africa Radiopharmaceutical Freeze-Dried Products Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Radiopharmaceutical Freeze-Dried Products Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Radiopharmaceutical Freeze-Dried Products Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Rosatom
- 12.1.1 Rosatom Company Information
- 12.1.2 Rosatom Business Overview
- 12.1.3 Rosatom Revenue in Radiopharmaceutical Freeze-Dried Products Business (2021-2026)
- 12.1.4 Rosatom Radiopharmaceutical Freeze-Dried Products Product Portfolio
- 12.1.5 Rosatom Recent Developments
- 12.2 NTP
- 12.2.1 NTP Company Information
- 12.2.2 NTP Business Overview
- 12.2.3 NTP Revenue in Radiopharmaceutical Freeze-Dried Products Business (2021-2026)
- 12.2.4 NTP Radiopharmaceutical Freeze-Dried Products Product Portfolio
- 12.2.5 NTP Recent Developments
- 12.3 NRG
- 12.3.1 NRG Company Information
- 12.3.2 NRG Business Overview
- 12.3.3 NRG Revenue in Radiopharmaceutical Freeze-Dried Products Business (2021-2026)
- 12.3.4 NRG Radiopharmaceutical Freeze-Dried Products Product Portfolio
- 12.3.5 NRG Recent Developments
- 12.4 IRE
- 12.4.1 IRE Company Information
- 12.4.2 IRE Business Overview
- 12.4.3 IRE Revenue in Radiopharmaceutical Freeze-Dried Products Business (2021-2026)
- 12.4.4 IRE Radiopharmaceutical Freeze-Dried Products Product Portfolio
- 12.4.5 IRE Recent Developments
- 12.5 ANSTO
- 12.5.1 ANSTO Company Information
- 12.5.2 ANSTO Business Overview
- 12.5.3 ANSTO Revenue in Radiopharmaceutical Freeze-Dried Products Business (2021-2026)
- 12.5.4 ANSTO Radiopharmaceutical Freeze-Dried Products Product Portfolio
- 12.5.5 ANSTO Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst